Navigating Healthcare Real Estate: Shifts in Life Sciences and MOB Investment

By RadCRE Research · 2026-09-30 · Industry Insights

Amidst evolving investment strategies, National Healthcare Properties divests 40 outpatient medical facilities for approximately $531 million [2].

Evolving Investment Landscape in Life Sciences and Medical Office Properties

The specialized sectors of life sciences and medical office buildings (MOBs) continue to attract significant attention within commercial real estate, albeit with nuanced investment strategies emerging. Recent transactions and strategic shifts highlight a dynamic environment driven by both long-term demographic trends and investor preferences for specific asset classes within healthcare real estate [2].

Investment in the life sciences sector, encompassing research and development (R&D) facilities, remains robust. JLL Capital Markets recently orchestrated the $43.5 million sale of two R&D manufacturing properties in Andover, Massachusetts. These fully leased properties, totaling 171,764 square feet, were acquired by Hendrie Lane Capital and V12 Investments from Ciminelli Real Estate Corporation and Gordon Brothers. Notably, three of the four tenants in these facilities operate their headquarters there, spanning critical sectors including medical device, musical instrument, aerospace, and analytical instrumentation [3]. This transaction underscores ongoing demand for mission-critical R&D assets, which are integral to the innovation ecosystem. CBRE's U.S. Real Estate Market Outlook Midyear Review 2026 also features a dedicated chapter on Life Sciences, signaling its importance as a distinct and watched sector [1].

Conversely, the medical office building sector is experiencing strategic realignments among major players. National Healthcare Properties (NHP) is undergoing a significant transformation, actively rotating out of medical office properties to concentrate on senior housing. NHP has entered a definitive agreement to sell 40 outpatient medical facilities for approximately $531 million, with plans to fully divest its medical office portfolio. This shift is predicated on NHP's assessment that senior housing offers stronger near-term operating momentum and benefits from a powerful demographic runway. While MOBs remain a liquid sector, NHP’s decision reflects a perception of increasing institutionalization within the space, where scale and specialized operating capabilities are becoming increasingly critical [2]. Despite NHP's exit, Cushman & Wakefield continues to offer valuation and advisory services for healthcare, including senior housing and healthcare properties, indicating continued market activity and the need for expert assessment in the broader healthcare real estate spectrum [5].

RadCRE Perspective

"The strategic rotation by National Healthcare Properties from medical office to senior housing is a prime example of investors recalibrating their portfolios to align with perceived demographic tailwinds and operational strengths. While life sciences R&D facilities demonstrate sustained demand for specialized, mission-critical assets, the MOB sector is clearly undergoing a maturation where efficiency, scale, and specialized management are becoming paramount for competitive advantage. Our focus at RadCRE remains on identifying opportunities where value can be created through deep market understanding and strategic positioning, whether it's in the robust life sciences sector or in re-positioned healthcare assets." – Majid Radaei, Founder & Principal Broker, Rad Commercial Realty

Tags: Life Sciences Real Estate, Medical Office Buildings, Healthcare REITs, R&D Facilities, CRE Investment Sales